Identification of Novel Immunotherapy Targets in Myeloma
Demographics (1)
- SEX - Biological sex (phv00543605.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for Multiple Myeloma (MM); all subjects are MM patients. (phv00543611.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00543618.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00543612.v1.p1)
Other (17)
- 1Q_STATUS - Status of chromosome 1q (phv00543621.v1.p1)
- 7_MOLECULAR_SUBGROUPS - Status of 7 defined molecular subgroups (phv00543623.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00543616.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00543615.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00543604.v1.p1)
- HYPERDIPOLID_STATUS - Status of hyperdiploidy (phv00543619.v1.p1)
- IS_TUMOR - Tumor status (phv00543617.v1.p1)
- PRIMARY_STATUS - Status of primary events (phv00543620.v1.p1)
- SAMPLE_ID - Sample ID (phv00543614.v1.p1)
- SAMPLE_ID - Sample ID (phv00543609.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID in dbGaP (phv00543607.v1.p1)
- STAGE - Disease Stage (phv00543613.v1.p1)
- SUBJECT_ID - Subject ID (phv00543603.v1.p1)
- SUBJECT_ID - Subject ID (phv00543610.v1.p1)
- SUBJECT_ID - Subject ID (phv00543608.v1.p1)
- SUBJECT_SOURCE - Subject repository in dbGaP (phv00543606.v1.p1)
- TP53_STATUS - Status of TP53 abnormality (phv00543622.v1.p1)